{"id":4127,"date":"2026-11-02T09:00:00","date_gmt":"2026-11-02T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=4127"},"modified":"2026-11-07T16:07:51","modified_gmt":"2026-11-07T20:07:51","slug":"gak-emerges-as-a-preclinical-dlbcl-mitotic-dependency","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=4127","title":{"rendered":"GAK Emerges as a Preclinical DLBCL Mitotic Dependency"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"768\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities-768x768.png\" alt=\"\" class=\"attachment-medium_large size-medium_large wp-image-4143\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities-768x768.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities-300x300.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities-1024x1024.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities-150x150.png 150w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261106_Farag_Lab_Technology_and_Modalities.png 1254w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/><\/p>\n<p><strong>Company<\/strong><\/p>\n<p>Farag Lab (academic)<\/p>\n<p><strong>Event Type<\/strong><\/p>\n<p>Peer-reviewed publication (Leukemia)<\/p>\n<p><strong>Modality<\/strong><\/p>\n<p>Small molecule target discovery<\/p>\n<p><strong>Asset<\/strong><\/p>\n<p>GAK-active compounds (preclinical)<\/p>\n<p><strong>Target<\/strong><\/p>\n<p>Cyclin G-associated kinase (GAK)<\/p>\n<p><strong>Disease Area<\/strong><\/p>\n<p>Diffuse large B-cell lymphoma<\/p>\n<h4>Summary<\/h4>\n<p>Previously missed peer-reviewed Leukemia paper published online November 2 identifies cyclin G-associated kinase (GAK) as a candidate vulnerability across diffuse large B-cell lymphoma models. The work combines phenotypic kinase-probe screening with target deconvolution; it is preclinical and does not show patient benefit.<\/p>\n<p>Investigators report that GAK kinase function supports mitotic progression, with inhibition causing G2\/M arrest and death. RB loss appeared to increase sensitivity. GAK-active compounds, including repurposed clinical molecules, showed anti-lymphoma activity in mouse xenografts. The paper does not establish a selective drug candidate with clinical exposure and safety in DLBCL.<\/p>\n<h4>Deep Analysis<\/h4>\n<p><strong>Interpretation A:<\/strong> GAK may address a lymphoma vulnerability distinct from canonical BCR signaling and create a biomarker-linked small-molecule path. Multi-model activity and genetic\/mechanistic experiments support this. Counterargument: GAK has roles in endocytosis and normal cells; xenograft selectivity may not predict therapeutic index.<\/p>\n<p><strong>Interpretation B:<\/strong> the main advance is the screening and deconvolution method, with GAK a test case. A pharmacologically selective optimized inhibitor, normal-tissue safety, RB-stratified patient-derived models and clinical target engagement would decide.<\/p>\n<h4>Company and Product Background<\/h4>\n<p>Diffuse large B-cell lymphoma is an aggressive mature B-cell malignancy. GAK is a kinase involved in vesicular trafficking and, in this study, mitosis; inhibiting its kinase activity is proposed to stop malignant-cell division.<\/p>\n<h4>Signal Extraction<\/h4>\n<ul>\n<li>Repurposed compound activity is not proof of GAK-specific clinical efficacy.<\/li>\n<li>Disease heterogeneity, CNS penetration, PK\/PD, mitotic toxicity, resistance and IP around selective chemistry remain open.<\/li>\n<\/ul>\n<h4>InSilens Take<\/h4>\n<p>The target merits medicinal chemistry and human-tissue validation; competitive displacement of established DLBCL treatments is premature.<\/p>\n<h4>Signal Assessment<\/h4>\n<p>Signal Importance: 3 of 5. Signal Direction: positive for target discovery; uncertain for therapy. Confidence in Facts: high for peer-reviewed experiments. Confidence in Interpretation: low to moderate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Previously missed peer-reviewed Leukemia paper published online November 2 identifies cyclin G-associated kinase (GAK) as a candidate vulnerability across diffuse large B-cell lymphoma models. The work combines phenotypic kinase-probe screening with target deconvolution; it&#8230;<\/p>\n","protected":false},"author":1,"featured_media":4143,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[1309,1398,1399],"class_list":["post-4127","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology-modalities","tag-dlbcl","tag-farag-lab","tag-gak"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4127"}],"version-history":[{"count":1,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4127\/revisions"}],"predecessor-version":[{"id":4149,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4127\/revisions\/4149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/4143"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}